Notice: This company has been marked as potentially delisted and may not be actively trading. Proteon Therapeutics (PRTO) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends PRTO vs. INBX, EDIT, ZURA, CMPX, OPT, CRBU, KYTX, TNYA, ADAP, and TILShould you be buying Proteon Therapeutics stock or one of its competitors? The main competitors of Proteon Therapeutics include Inhibrx (INBX), Editas Medicine (EDIT), Zura Bio (ZURA), Compass Therapeutics (CMPX), Opthea (OPT), Caribou Biosciences (CRBU), Kyverna Therapeutics (KYTX), Tenaya Therapeutics (TNYA), Adaptimmune Therapeutics (ADAP), and Instil Bio (TIL). These companies are all part of the "medical" sector. Proteon Therapeutics vs. Inhibrx Editas Medicine Zura Bio Compass Therapeutics Opthea Caribou Biosciences Kyverna Therapeutics Tenaya Therapeutics Adaptimmune Therapeutics Instil Bio Proteon Therapeutics (NASDAQ:PRTO) and Inhibrx (NASDAQ:INBX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation, community ranking and profitability. Do institutionals and insiders hold more shares of PRTO or INBX? 23.0% of Proteon Therapeutics shares are owned by institutional investors. Comparatively, 82.5% of Inhibrx shares are owned by institutional investors. 45.7% of Proteon Therapeutics shares are owned by insiders. Comparatively, 22.2% of Inhibrx shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is PRTO or INBX more profitable? Proteon Therapeutics' return on equity of 0.00% beat Inhibrx's return on equity.Company Net Margins Return on Equity Return on Assets Proteon TherapeuticsN/A N/A -118.68% Inhibrx N/A -113.74%-80.56% Which has stronger valuation and earnings, PRTO or INBX? Proteon Therapeutics has higher earnings, but lower revenue than Inhibrx. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProteon TherapeuticsN/AN/A-$20.73M-$1.15-2.08Inhibrx$1.63M125.08-$154.96MN/AN/A Does the media prefer PRTO or INBX? In the previous week, Inhibrx had 7 more articles in the media than Proteon Therapeutics. MarketBeat recorded 7 mentions for Inhibrx and 0 mentions for Proteon Therapeutics. Inhibrx's average media sentiment score of 1.01 beat Proteon Therapeutics' score of 0.00 indicating that Inhibrx is being referred to more favorably in the news media. Company Overall Sentiment Proteon Therapeutics Neutral Inhibrx Positive Do analysts prefer PRTO or INBX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Proteon Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Inhibrx 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community prefer PRTO or INBX? Proteon Therapeutics received 241 more outperform votes than Inhibrx when rated by MarketBeat users. Likewise, 69.21% of users gave Proteon Therapeutics an outperform vote while only 59.62% of users gave Inhibrx an outperform vote. CompanyUnderperformOutperformProteon TherapeuticsOutperform Votes27269.21% Underperform Votes12130.79% InhibrxOutperform Votes3159.62% Underperform Votes2140.38% SummaryInhibrx beats Proteon Therapeutics on 6 of the 11 factors compared between the two stocks. Ad Awesomely, LLCAutomatic Income (from home)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video Get Proteon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTO vs. The Competition Export to ExcelMetricProteon TherapeuticsBiological Products, Except Diagnostic IndustryMedical SectorNASDAQ ExchangeMarket Cap$53.01M$3.02B$5.21B$8.81BDividend YieldN/A1.86%5.54%4.07%P/E Ratio-2.0845.6296.5017.88Price / SalesN/A360.941,207.8590.18Price / CashN/A172.5641.7436.95Price / Book-39.834.607.246.54Net Income-$20.73M-$41.63M$119.96M$226.07M Proteon Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTOProteon TherapeuticsN/A$2.39+4.4%N/A+112.4%$53.01MN/A-2.0817INBXInhibrx1.8727 of 5 stars$13.98-0.4%N/A-31.5%$202.43M$1.63M0.00166Insider TradeNews CoveragePositive NewsEDITEditas Medicine4.7282 of 5 stars$2.37-1.7%$9.08+283.3%-76.7%$198.94M$61.76M-0.93230Analyst RevisionZURAZura Bio3.892 of 5 stars$2.93+1.0%$15.80+439.2%-35.6%$191.30MN/A0.003CMPXCompass Therapeutics3.306 of 5 stars$1.38+0.7%$6.75+389.1%-13.4%$189.87MN/A-3.7320OPTOpthea2.2077 of 5 stars$3.13-4.6%$12.00+283.4%+64.6%$182.79M$120,000.000.008CRBUCaribou Biosciences2.3362 of 5 stars$1.98+1.0%$11.25+468.2%-64.5%$179.29M$34.48M-1.20100KYTXKyverna Therapeutics2.7744 of 5 stars$3.99-3.2%$25.71+544.5%N/A$172.25M$7.03M0.0096Analyst ForecastAnalyst RevisionNews CoverageTNYATenaya Therapeutics3.9446 of 5 stars$2.16-2.7%$14.75+582.9%+34.5%$171.12MN/A-1.50110News CoverageHigh Trading VolumeADAPAdaptimmune Therapeutics2.3094 of 5 stars$0.63-4.5%$3.16+399.5%+47.3%$170.09M$175.04M-2.88449TILInstil Bio3.1032 of 5 stars$24.67+5.6%$145.00+487.8%+252.0%$152.45MN/A-2.1349 Related Companies and Tools Related Companies Inhibrx Alternatives Editas Medicine Alternatives Zura Bio Alternatives Compass Therapeutics Alternatives Opthea Alternatives Caribou Biosciences Alternatives Kyverna Therapeutics Alternatives Tenaya Therapeutics Alternatives Adaptimmune Therapeutics Alternatives Instil Bio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRTO) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could...Investors Alley | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteon Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Proteon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTO Stock Alerts